Back to Search Start Over

Current Threat of Triclabendazole Resistance in Fasciola hepatica.

Authors :
Kelley JM
Elliott TP
Beddoe T
Anderson G
Skuce P
Spithill TW
Source :
Trends in parasitology [Trends Parasitol] 2016 Jun; Vol. 32 (6), pp. 458-469. Date of Electronic Publication: 2016 Apr 02.
Publication Year :
2016

Abstract

Triclabendazole (TCBZ) is the only chemical that kills early immature and adult Fasciola hepatica (liver fluke) but widespread resistance to the drug greatly compromises fluke control in livestock and humans. The mode of action of TCBZ and mechanism(s) underlying parasite resistance to the drug are not known. Due to the high prevalence of TCBZ resistance (TCBZ-R), effective management of drug resistance is now critical for sustainable livestock production. Here, we discuss the current status of TCBZ-R in F. hepatica, the global distribution of resistance observed in livestock, the possible mechanism(s) of drug action, the proposed mechanisms and genetic basis of resistance, and the prospects for future control of liver fluke infections using an integrated parasite management (IPM) approach.<br /> (Copyright © 2016 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1471-5007
Volume :
32
Issue :
6
Database :
MEDLINE
Journal :
Trends in parasitology
Publication Type :
Academic Journal
Accession number :
27049013
Full Text :
https://doi.org/10.1016/j.pt.2016.03.002